Andrea Napolitano

17PUBLICATIONS
70CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceAboriginal and Torres Strait Islander marketingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 11, 2025
Efficacy and cardiac safety of aldoxorubicin in metastatic solitary fibrous tumour.

Karolina Vosylius, Gareth Price, Andrea Napolitano

|Nov 08, 2024
The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma.

Foteini Kalofonou, Andrea Napolitano, Charlotte Benson

|Aug 12, 2024
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Anna Maria Frezza, Hugh Leonard, Ninna Aggerholm-Pedersen

|Aug 01, 2024
First-Line Tyrosine Kinase Inhibitors in Soft-Tissue Sarcomas: A Role for Anlotinib?

Andrea Napolitano, Paul H Huang, Robin L Jones

|Mar 13, 2024
Efficacy and Safety of Ripretinib in Advanced Gastrointestinal Stromal Tumors within an Expanded Access Program: A Cohort Study.

Su Yin Lim, Laura Ferro-López, Elizabeth Barquin

|Oct 05, 2022
Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.

Bruno Vincenzi, Andrea Napolitano, Alessandro Comandone

Pageof 3

Frequent Collaborators

3 joint publications

Robin L Jones

2 joint publications

Michele Iuliani

2 joint publications

Jean-Yves Blay

2 joint publications

Bruno Vincenzi